AgNOR检测在卵巢良、恶性肿瘤鉴别诊断中的价值  

Evaluate AgNOR test in Distinctively Diagnosis of Ovarian Tumor

作　　者：肖颖[1] 盛传家[1] 

机构地区：[1]福建省福州市第二医院病理科,福建福州350007

出　　处：《河北医学》2006年第3期204-205,共2页Hebei Medicine

摘　　要：目的:AgNOR检测应用于卵巢肿瘤的鉴别诊断。方法:选择已确诊94例卵巢肿瘤,良性卵巢粘液性囊腺瘤47例,卵巢粘液性囊腺癌24例,交界性卵巢囊腺瘤23例。分别对三组进行Ag-NOR检测。结果:良恶性两组比较有显著差异(p<0.01)、交界组界于两面者之间。结论:AgNOR计数与肿瘤的恶性度大体上呈正比,对良恶性卵巢肿瘤鉴别及分类,分型、分级有一定价值。Objective： To evaluate AgNOR test in distinctively diagnosis of ovarian tumor. Method： To analyze ovarian tumor diagnosised of 94 cases take AgNOR test and there are three classes serious eystadenoma of 47 cases, mueinous cystadenoearcinoma of 24 cases and bordering cystadenoma of 23 cases. Result： The sight between serious eystadenoma and mucinous cytadnocareinoma was significant （p 〈 0.01 ） and bordering eystadenoma was borderd by them. Conclusion： AgNOR calculated was as deeply as ovarian tumor and to evaluate for them in distinctively diagnosis of the deep and class.

关 键 词：AGNOR 卵巢肿瘤 

分 类 号：R737.31[医药卫生—肿瘤]